Delivery Order SPE2DR25D2002-SPE2DR26FBTC5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,271.35 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalation powder (60-count supply) on January 6, 2026, with completion expected by January 7, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The award leverages AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $1,768.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units). This is a non-set-aside, competitively awarded contract with a completion date of January 7, 2026, and performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $12,750.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,705.24 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 12, 2025. This non-competitive, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,143.65 for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a direct purchase under an existing contract vehicle. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $36,573.09 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count) on November 10, 2025, with completion targeted for November 12, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $28,879.57 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. Issued on November 17, 2025, with an ultimate completion date of November 18, 2025, this firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contract is being fulfilled from the company's place of performance in...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBTC5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,511.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalation powder (60-count units) on January 8, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 9, 2026. The award represents a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems worldwide. TRELEGY ELLIPTA is a combination respiratory medication used for chronic obstructive pulmonary disease management, reflecting the broad pharmaceutical portfolio AmerisourceBergen supplies through its DLA contract vehicle. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), also maintains a larger IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, demonstrating the company's ongoing role as a primary vendor for military healthcare pharmaceutical needs. This delivery order exemplifies the routine execution of the IDC for supplying specialty medications, brand-name and generic drugs, and related medical commodities to support military treatment facilities and federal healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/7/26 |